14 results on '"Forel, Jean-Marie"'
Search Results
2. Modes of administration of nitric oxide devices and ventilators flow-by impact the delivery of pre-determined concentrations
- Author
-
Vuillermoz, Alice, Lefranc, Mathilde, Prouvez, Nathan, Brault, Clément, Zerbib, Yoann, Schmitt, Mary, Forel, Jean-Marie, Le Tutour, Mathieu, Lesimple, Arnaud, Mercat, Alain, Richard, Jean-Christophe, and Beloncle, François M.
- Published
- 2024
- Full Text
- View/download PDF
3. Outcomes of Severe ARDS COVID-19 Patients Denied for Venovenous ECMO Support: A Prospective Observational Comparative Study.
- Author
-
Sylvestre, Aude, Forel, Jean-Marie, Textoris, Laura, Gragueb-Chatti, Ines, Daviet, Florence, Salmi, Saida, Adda, Mélanie, Roch, Antoine, Papazian, Laurent, Hraiech, Sami, and Guervilly, Christophe
- Subjects
- *
COVID-19 , *ADULT respiratory distress syndrome , *EXTRACORPOREAL membrane oxygenation - Abstract
Background: Few data are available concerning the outcome of patients denied venovenous extracorporeal membrane oxygenation (VV-ECMO) relative to severe acute respiratory distress syndrome (ARDS) due to COVID-19. Methods: We compared the 90-day survival rate of consecutive adult patients for whom our center was contacted to discuss VV-ECMO indication. Three groups of patients were created: patients for whom VV-ECMO was immediately indicated (ECMO-indicated group), patients for whom VV-ECMO was not indicated at the time of the call (ECMO-not-indicated group), and patients for whom ECMO was definitely contraindicated (ECMO-contraindicated group). Results: In total, 104 patients were referred for VV-ECMO support due to severe COVID-19 ARDS. Among them, 32 patients had immediate VV-ECMO implantation, 28 patients had no VV-ECMO indication, but 1 was assisted thereafter, and 44 patients were denied VV-ECMO for contraindication. Among the 44 patients denied, 30 were denied for advanced age, 24 for excessive prior duration of mechanical ventilation, and 16 for SOFA score >8. The 90-day survival rate was similar for the ECMO-indicated group and the ECMO-not-indicated group at 62.1 and 61.9%, respectively, whereas it was significantly lower (20.5%) for the ECMO-contraindicated group. Conclusions: Despite a low survival rate, 50% of patients were at home 3 months after being denied for VV-ECMO for severe ARDS due to COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO
- Author
-
Hraiech, Sami, Bonnardel, Eline, Guervilly, Christophe, Fabre, Cyprien, Loundou, Anderson, Forel, Jean-Marie, Adda, Mélanie, Parzy, Gabriel, Cavaille, Guilhem, Coiffard, Benjamin, Roch, Antoine, and Papazian, Laurent
- Published
- 2019
- Full Text
- View/download PDF
5. Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome
- Author
-
Hamon, Annabelle, Scemama, Ugo, Bourenne, Jérémy, Daviet, Florence, Coiffard, Benjamin, Persico, Nicolas, Adda, Mélanie, Guervilly, Christophe, Hraiech, Sami, Chaumoitre, Kathia, Roch, Antoine, Papazian, Laurent, and Forel, Jean-Marie
- Published
- 2019
- Full Text
- View/download PDF
6. Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome
- Author
-
Guervilly, Christophe, Bisbal, Magali, Forel, Jean Marie, Mechati, Malika, Lehingue, Samuel, Bourenne, Jeremy, Perrin, Gilles, Rambaud, Romain, Adda, Melanie, Hraiech, Sami, Marchi, Elisa, Roch, Antoine, Gainnier, Marc, and Papazian, Laurent
- Published
- 2017
- Full Text
- View/download PDF
7. Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center
- Author
-
Roch, Antoine, Hraiech, Sami, Masson, Elodie, Grisoli, Dominique, Forel, Jean-Marie, Boucekine, Mohamed, Morera, Pierre, Guervilly, Christophe, Adda, Mélanie, Dizier, Stéphanie, Toesca, Richard, Collart, Fréderic, and Papazian, Laurent
- Published
- 2014
- Full Text
- View/download PDF
8. Transforming Growth Factor-β1 in predicting early lung fibroproliferation in patients with acute respiratory distress syndrome.
- Author
-
Forel, Jean-Marie, Guervilly, Christophe, Farnarier, Catherine, Donati, Stéphane-Yannis, Hraiech, Sami, Persico, Nicolas, Allardet-Servent, Jérôme, Coiffard, Benjamin, Gainnier, Marc, Loundou, Anderson, Sylvestre, Aude, Roch, Antoine, Bourenne, Jeremy, and Papazian, Laurent
- Subjects
- *
TRANSFORMING growth factors-beta , *ADULT respiratory distress syndrome , *LUNG injuries , *BRONCHOALVEOLAR lavage , *IMMUNOASSAY - Abstract
Background: Fibroproliferative repair phase of the acute respiratory distress syndrome (ARDS) is followed by a restitutio ad integrum of lung parenchyma or by an irreversible lung fibrosis and patients’ death. Transforming Growth Factor-β1 (TGF-β1) is involved in collagen production and lung repair. We investigated whether alveolar TGF-β1 was associated with the presence of fibroproliferation and the outcome of ARDS patients. Methods: Sixty-two patients were included the first day of moderate-to-severe ARDS. Bronchoalveolar lavage fluid (BALF) was collected at day 3 (and day 7 when the patients were still receiving invasive mechanical ventilation) from the onset of ARDS. Survival was evaluated at day 60. TGF-β1 was measured by immunoassay. The patients were classified as having lung fibroproliferation when the alveolar N-terminal peptide for type III procollagen (NT-PCP-III) measured on day 3 was > 9 μg/L as recently reported. The main objective of this study was to compare the alveolar levels of total TGF-β1 according to the presence or not a lung fibroproliferation at day 3. Results: Forty-three patients (30.6%) presented a fibroproliferation at day 3. BALF levels of total TGF-β1 were not statistically different at day 3 (and at day 7) according to the presence or not lung fibroproliferation. Mortality at day 60 was higher in the group of patients with fibroproliferation as compared with patients with no fibroproliferation (68.4% vs. 18.6% respectively; p < 0.001). Total TGF-β1 measured on BALF at day 3 was not associated with the outcome. Multiple logistic regression showed that the presence of lung fibroproliferation was associated with death. In contrast, TGF-β1 was not independently associated with death. Conclusions: Pulmonary levels of TGF-β1 during the first week of ARDS were not associated nor with the presence of fibroproliferation neither with death. TGF-β1 should not be used as a biomarker to direct anti-fibrotic therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
9. Timing of Renal Support and Outcome of Septic Shock and Acute Respiratory Distress Syndrome: A Post Hoc Analysis of the AKIKI Randomized Clinical Trial.
- Author
-
Gaudry, Stéphane, Hajage, David, Schortgen, Frédérique, Martin-Lefevre, Laurent, Verney, Charles, Pons, Bertrand, Boulet, Eric, Boyer, Alexandre, Chevrel, Guillaume, Lerolle, Nicolas, Carpentier, Dorothée, de Prost, Nicolas, Lautrette, Alexandre, Bretagnol, Anne, Mayaux, Julien, Nseir, Saad, Megarbane, Bruno, Thirion, Marina, Forel, Jean-Marie, and Maizel, Julien
- Subjects
SEPTIC shock ,ADULT respiratory distress syndrome ,CLINICAL trials ,ACUTE kidney failure ,MORTALITY - Abstract
Rationale: The optimal strategy for initiation of renal replacement therapy (RRT) in patients with severe acute kidney injury in the context of septic shock and acute respiratory distress syndrome (ARDS) is unknown. Objectives: To examine the effect of an early compared with a delayed RRT initiation strategy on 60-day mortality according to baseline sepsis status, ARDS status, and severity. Methods: Post hoc analysis of the AKIKI (Artificial Kidney Initiation in Kidney Injury) trial. Measurements and Main Results: Subgroups were defined according to baseline characteristics: sepsis status (Sepsis-3 definition), ARDS status (Berlin definition), Simplified Acute Physiology Score 3 (SAPS 3), and Sepsis-related Organ Failure Assessment (SOFA). Of 619 patients, 348 (56%) had septic shock and 207 (33%) had ARDS. We found no significant influence of the baseline sepsis status (P = 0.28), baseline ARDS status (P = 0.94), and baseline severity scores (P = 0.77 and P = 0.46 for SAPS 3 and SOFA, respectively) on the comparison of 60-day mortality according to RRT initiation strategy. A delayed RRT initiation strategy allowed 45% of patients with septic shock and 46% of patients with ARDS to escape RRT. Urine output was higher in the delayed group. Renal function recovery occurred earlier with the delayed RRT strategy in patients with septic shock or ARDS (P,0.001 and P = 0.003, respectively). Time to successful extubation in patients with ARDS was not affected by RRT strategy (P = 0.43). Conclusions: Early RRT initiation strategy was not associated with any improvement of 60-day mortality in patients with severe acute kidney injury and septic shock or ARDS. Unnecessary and potentially risky procedures might often be avoided in these fragile populations. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Right ventricular function during high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome.
- Author
-
Guervilly, Christophe, Forel, Jean-Marie, Hraiech, Sami, Demory, Didier, Allardet-Servent, Jérome, Adda, Mélanie, Barreau-Baumstark, Karine, Castanier, Matthias, Papazian, Laurent, and Roch, Antoine
- Subjects
- *
RIGHT heart ventricle , *HIGH-frequency ventilation (Therapy) , *ADULT respiratory distress syndrome , *ECHOCARDIOGRAPHY , *CRITICAL care medicine - Abstract
The article presents a study which evaluates the effect of mean airway pressure (mPaw) under high-frequency oscillatory ventilation (HFOV) on right ventricular function. It is inferred that 16 patients with pulmonary acute respiratory distress syndrome (ARDS) were examined. According to the study, the use of mPaw under HFOV worsens right ventricular function in patients with ARDS.
- Published
- 2012
- Full Text
- View/download PDF
11. FI02 and acute respiratory distress syndrome definition during lung protective ventilation.
- Author
-
Allardet-Servent, Jérôme, Forel, Jean-Marie, Roch, Antoine, Guervilly, Christophe, Chiche, Laurent, Castanier, Matthias, Embriaco, Nathalie, Gainnier, Marc, and Papazian, Laurent
- Subjects
- *
ARTIFICIAL respiration , *LUNGS , *PATIENTS , *RESPIRATORY distress syndrome , *CRITICAL care medicine - Abstract
The article examines the effect of high FI02 levels on the course of Pa02/FI02 ratio (P/F) in lung protective mechanically ventilated patients with acute respiratory distress syndrome. According to the authors, P/F variation was responsible for two thirds of patients changing from the acute respiratory distress syndrome to the acute lung injury stage of the American-European Consensus Conference definition.
- Published
- 2009
- Full Text
- View/download PDF
12. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.
- Author
-
Parzy, Gabriel, Daviet, Florence, Puech, Basile, Sylvestre, Aude, Guervilly, Christophe, Porto, Alizée, Hraiech, Sami, Chaumoitre, Kathia, Papazian, Laurent, and Forel, Jean-Marie
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *COVID-19 , *COVID-19 pandemic , *VENOUS thrombosis , *ADULT respiratory distress syndrome , *CORONAVIRUS disease treatment , *SARS treatment , *VIRAL pneumonia , *INTENSIVE care units , *VEINS , *ACADEMIC medical centers , *SPECIALTY hospitals , *ANTICOAGULANTS , *RETROSPECTIVE studies , *HOSPITAL mortality , *TREATMENT effectiveness , *CATASTROPHIC illness , *RISK assessment , *THROMBOEMBOLISM , *EPIDEMICS , *CRITICAL care medicine , *COMPUTED tomography , *SARS disease , *LONGITUDINAL method - Abstract
Objectives: The main objective of the study was to determine the prevalence of venous thromboembolism events in patients infected with severe acute respiratory syndrome coronavirus 2 requiring venovenous extracorporeal membrane oxygenation. The secondary objective was to compare venous thromboembolism events and coagulation variables in patients requiring venovenous extracorporeal membrane oxygenation according to the pathogen.Design: Retrospective observational analysis at a single center.Setting: Tertiary referral university teaching hospital.Patients: Patients with severe acute respiratory syndrome coronavirus 2-related severe acute respiratory distress syndrome requiring venovenous extracorporeal membrane oxygenation therapy with an injected CT scan performed after extracorporeal membrane oxygenation retrieval.Interventions: None.Measurements and Main Results: We included 13 severe acute respiratory syndrome coronavirus 2 patients requiring venovenous extracorporeal membrane oxygenation. All of these patients experienced venous thromboembolism: 10 patients (76.9%) had isolated cannula-associated deep vein thrombosis, two patients (15.4%) had isolated pulmonary embolism, and one patient (7.7%) had both cannula-associated deep vein thrombosis and pulmonary embolism. Eleven patients (84.6%) had cannula-associated deep vein thrombosis. A jugular associated cannula-associated deep vein thrombosis was identified in seven patients (53.8%), a femoral associated cannula-associated deep vein thrombosis was identified in 10 patients (76.9%), and six patients (46.2%) had both femoral and jugular cannula-associated deep vein thrombosis. A pulmonary embolism was found in three patients (23.1%). No patient had central venous catheter-related deep vein thrombosis. One patient had thrombotic occlusion of the centrifugal pump, and one had oxygenator thrombosis requiring circuit replacement. Three patients (23.1%) had significant bleeding. Three patients (23.1%) had laboratory-confirmed heparin-induced thrombocytopenia, and all of them developed cannula-associated deep vein thrombosis. These three patients had femoral cannula-associated deep vein thrombosis, and two had an oxygenator or pump thrombosis. The mean activated partial thromboplastin time ratio was higher in the severe acute respiratory syndrome coronavirus 2 group than in the influenza group and the community-acquired pneumonia group (1.91 vs 1.48 vs 1.53; p = 0.001), which was also found in regard to the percentage of patients with an activated partial thromboplastin time ratio greater than 1.8 (47.8% vs 20% vs 20.9%; p = 0.003) and the mean prothrombin ratio (86.3 vs 61.6 vs 67.1; p = 0.003). There was no difference in baseline characteristics or venous thromboembolism events.Conclusions: We report a 100% occurrence of venous thromboembolism in critically ill patients supported by venovenous extracorporeal membrane oxygenation for severe acute respiratory syndrome coronavirus 2-related acute respiratory distress syndrome using CT scan imaging despite a high target and close monitoring of anticoagulation. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
13. Prevalence and Risk Factors for Thrombotic Complications Following Venovenous Extracorporeal Membrane Oxygenation: A CT Scan Study.
- Author
-
Parzy, Gabriel, Daviet, Florence, Persico, Nicolas, Rambaud, Romain, Scemama, Ugo, Adda, Mélanie, Guervilly, Christophe, Hraiech, Sami, Chaumoitre, Kathia, Roch, Antoine, Papazian, Laurent, and Forel, Jean-Marie
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *VENOUS thrombosis , *ADULT respiratory distress syndrome , *CARDIOGENIC shock , *PARTIAL thromboplastin time , *LOGISTIC regression analysis , *HEPATIC veno-occlusive disease , *ADULT respiratory distress syndrome treatment , *INTENSIVE care units , *ACADEMIC medical centers , *RETROSPECTIVE studies , *DISEASE prevalence , *CATHETERIZATION , *COMPUTED tomography - Abstract
Objectives: The aims of this study were to: 1) analyze the cannula-associated deep vein thrombosis frequency after venovenous extracorporeal membrane oxygenation using a CT scan and 2) identify the associated risk factors for cannula-associated deep vein thrombosis.Design: Retrospective observational analysis at a single center.Setting: Tertiary referral university teaching hospital.Patients: Patients under venovenous extracorporeal membrane oxygenation with a femorofemoral or femorojugular cannulation admitted for acute respiratory distress syndrome or primary graft dysfunction after pulmonary transplantation. CT scan was performed within 4 days after decannulation.Interventions: None.Measurements and Main Results: We included 105 of 228 patients screened. Bacterial pneumonia was the main indication of venovenous extracorporeal membrane oxygenation (46.7%). CT scans were performed at a median of 2 days (1-3 d) after decannulation. Cannula-associated deep vein thrombosis was found in 75 patients (71.4%) despite it having a mean activated partial thromboplastin time ratio of 1.60 ± 0.31. Femorofemoral cannulation induced femoral cannula-associated deep vein thrombosis more frequently than femorojugular cannulation (69.2% vs 63.1%, respectively; p = 0.04). Seventeen of the 105 patients (16.2%) had a pulmonary embolism. Multivariate logistic regression analysis showed that higher the percentage of thrombocytopenia less than 100 G/L during extracorporeal membrane oxygenation period, lower the risk for developing cannula-associated deep vein thrombosis (hazard ratio, 0.98; 95% CI, 0.98-1.00; p = 0.02).Conclusions: Cannula-associated deep vein thrombosis after venovenous extracorporeal membrane oxygenation is a frequent complication. This plead for a systematic vascular axis imaging after venovenous extracorporeal membrane oxygenation. Thrombocytopenia is associated with a reduction in the occurrence of thrombotic events. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
14. Failure to Improve the Oxygenation Index Is a Useful Predictor of Therapy Failure in Acute Respiratory Distress Syndrome Clinical Trials.
- Author
-
Go, Leonard, Scott Budinger, G. R., Kwasny, Mary J., Jie Peng, Forel, Jean-Marie, Papazian, Laurent, Jain, Manu, Budinger, G R Scott, and Peng, Jie
- Subjects
- *
HYPERBARIC oxygenation , *ADULT respiratory distress syndrome , *CLINICAL trials , *ARTIFICIAL respiration , *HEALTH outcome assessment , *COHORT analysis , *TREATMENT effectiveness , *ADULT respiratory distress syndrome treatment , *BLOOD gases analysis , *OXYGEN , *RESEARCH funding , *MECHANICAL ventilators , *PREDICTIVE tests , *RETROSPECTIVE studies - Abstract
Objective: Acute respiratory distress syndrome trials powered for mortality require significant resources, limiting the number of evaluable therapies. Validation of intermediate endpoints would enhance the feasibility of testing novel acute respiratory distress syndrome therapies in pilot studies and potentially reduce the frequency of failed large clinical trials. We sought to determine whether a change in the oxygenation index over the first 7 days of acute respiratory distress syndrome could discriminate between therapies likely or unlikely to show benefit in larger clinical trials.Design: A derivation cohort from three acute respiratory distress syndrome studies was used to estimate the 7-day change in oxygenation index. Receiver operating characteristic curves were used to calculate optimal thresholds and predictability of the change in oxygenation index for 28-day mortality and ventilator-free days. The thresholds were then validated in two cohorts. Then, for each individual acute respiratory distress syndrome study, the threshold 7-day oxygenation index change was tested as an outcome measure and compared with mortality and ventilator-free days as reported in the original study.Setting: Medical ICUs.Patients: Acute respiratory distress syndrome patients.Interventions: Various.Measurements and Main Results: Change in oxygenation index, 28-day mortality, and ventilator-free days. In the derivation cohort, the mean 7-day oxygenation index improved by 4.2 (± 11.7) in 28-day survivors compared with an increase of 2.4 (± 11.6) in 28-day nonsurvivors (p < 0.001). The mean 7-day oxygenation index decreased by 5.9 (± 8.4) in patients with more than 14 ventilator-free days, compared with a decrease of 1.9 (± 12.4) among those with less than 14 ventilator-free days (p = 0.001). The optimal 7-day oxygenation index threshold for predicting mortality was an increase of 1.71 and for predicting less than 14 ventilator-free days, a decrease of 2.34. When used as a surrogate endpoint, the optimal 7-day oxygenation index change closely approximated mortality and ventilator-free day outcomes in three Acute Respiratory Distress Syndrome Network studies used for the derivation cohort and a distinct study used for validation. The change in oxygenation index was a poor predictor of individual patient outcome.Conclusions: Failure to meet a threshold improvement in the oxygenation index over the first 7 days of therapy can be used to identify therapies unlikely to succeed in subsequent trials powered for mortality and ventilator-free days. By reducing trial time and costs, use of the 7-day oxygenation index change as an intermediate endpoint could increase the number of clinical trials of promising therapies for acute respiratory distress syndrome and reduce the number of large-scale trials of therapies unlikely to be of benefit. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.